Market Overview:
The global lapatinib ditosylate reagent market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of lapatinib ditosylate reagent in research and medical applications. Additionally, the growing demand for precision medicine is also contributing to the growth of this market. However, factors such as high cost and limited availability are restraining the growth of this market.
Product Definition:
Lapatinib Ditosylate Reagent is a drug that is used to treat cancer. It helps to stop the growth of tumor cells and may help to shrink tumors.
Min Purity Less Than 98%:
Min Purity Less Than 98% is a special type of pharmaceutical grade lapatinib ditosylate that has a purity level of 99.8%. It is used as an intermediate in the manufacturing process of various medicines such as Lapatinib (LPD), Abrilada, and others. The product helps to increase the yield during lapatinib production by avoiding impurities that may lower down the yield or even prevent its completion in some cases.
Min Purity 98%-99%:
Min Purity 98%-99% is a lapatinib ditosylate reagent that has been used in the preparation of pharmaceutical formulations. It contains almost no impurities and is suitable for human consumption. Lapatinib ditosylate reagents are used to formulate lapatinib as an oral drug product which has a purity level of more than 99%.
Application Insights:
Medical application dominated the global lapatinib ditosylate market in terms of revenue share in 2017. The growing number of cancer patients with EGFR mutations and resistance to chemotherapy is expected to be a high rendering driver for this growth. In addition, increasing research activities are being carried out for the development of new drugs that can overcome drug resistance associated with Platinum Group Therapeutic (PGT) compounds. This is further anticipated to boost demand over the forecast period.
Research application accounted for a significant share in 2017 and is expected to grow at lucrative CAGR during the forecast period owing to extensive R&D initiatives undertaken by various companies including Astrazeneca, Bristol-Myers Squibb, Pfizer & Sun Pharmaceutical Industries Ltd.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high R&D investment by companies and increased focus on cancer research & development. In addition, increasing number of clinical trials for Lapatinib Ditosylate is also expected to drive growth over the forecast period. Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with growing awareness about early diagnosis & treatment in emerging countries such as China and India.
In 2016, worldwide sales for lapatinib ditosylate were estimated at USD X million (€610 million). The U.S.
Growth Factors:
- Increasing incidence of cancer: The Lapatinib Ditosylate Reagent market is driven by the increasing incidence of cancer. According to the World Health Organization, there were 14 million new cases of cancer in 2012 and this number is expected to rise to 21 million by 2030. This will create a large demand for Lapatinib Ditosylate Reagent as it is used in the treatment of various types of cancers.
- Rising awareness about cancer: There has been a rising awareness about cancer in recent years due to campaigns by various organizations such as the American Cancer Society and Susan G Komen for the Cure Foundation. This has led to an increase in demand for Lapatinib Ditosylate Reagent as more people are seeking treatment for their cancers.
- Technological advancements: The Lapatinib Ditosylate Reagent market is also driven by technological advancements that have made it possible to develop better and more effective treatments for various types of cancers using lapatinib ditosylate reagents . These advancements are likely to continue, creating further growth opportunities for players operating in this market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Lapatinib Ditosylate Reagent Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
LGC, BOC Sciences, Shimadzu, Selleck Chemicals, Adooq Bioscience, ChemScence, Target Molecule, SimSon Pharma, APExBIO Technology, J&K Scientific, Aladdin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Lapatinib Ditosylate Reagent Market Report Segments:
The global Lapatinib Ditosylate Reagent market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LGC
- BOC Sciences
- Shimadzu
- Selleck Chemicals
- Adooq Bioscience
- ChemScence
- Target Molecule
- SimSon Pharma
- APExBIO Technology
- J&K Scientific
- Aladdin
Highlights of The Lapatinib Ditosylate Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lapatinib Ditosylate Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lapatinib ditosylate is a chemotherapy agent used to treat cancer. It works by blocking the growth of cancer cells.
Some of the key players operating in the lapatinib ditosylate reagent market are LGC, BOC Sciences, Shimadzu, Selleck Chemicals, Adooq Bioscience, ChemScence, Target Molecule, SimSon Pharma, APExBIO Technology, J&K Scientific, Aladdin.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lapatinib Ditosylate Reagent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lapatinib Ditosylate Reagent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lapatinib Ditosylate Reagent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lapatinib Ditosylate Reagent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lapatinib Ditosylate Reagent Market Size & Forecast, 2020-2028
4.5.1 Lapatinib Ditosylate Reagent Market Size and Y-o-Y Growth
4.5.2 Lapatinib Ditosylate Reagent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lapatinib Ditosylate Reagent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lapatinib Ditosylate Reagent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lapatinib Ditosylate Reagent Market: Competitive Dashboard
14.2 Global Lapatinib Ditosylate Reagent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 LGC
14.3.2 BOC Sciences
14.3.3 Shimadzu
14.3.4 Selleck Chemicals
14.3.5 Adooq Bioscience
14.3.6 ChemScence
14.3.7 Target Molecule
14.3.8 SimSon Pharma
14.3.9 APExBIO Technology
14.3.10 J&K Scientific
14.3.11 Aladdin
